Charlotte Fribert

Title: Charlotte Fribert: Innovator in Synthetic Viruses

Introduction

Charlotte Fribert is a notable inventor based in Paris, France. She has made significant contributions to the field of immunology through her innovative work on synthetic viruses. Her research focuses on developing compositions and methods that can produce an immune response, which is crucial for vaccine development.

Latest Patents

Charlotte Fribert holds a patent for her invention titled "Synthetic viruses and uses thereof." This patent relates to compositions and methods for producing an immune response or reaction, as well as to vaccines, kits, processes, cells, and their uses. More specifically, her invention utilizes synthetic viral particles to enhance or regulate immune responses in subjects. The compositions she developed serve as adjuvants or vehicles to stimulate immune responses against selected antigens or epitopes, particularly targeting both cellular and humoral immune responses.

Career Highlights

Charlotte Fribert is affiliated with L'Université Pierre et Marie Curie, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in vaccine technology and therapeutic interventions.

Collaborations

Charlotte has collaborated with esteemed colleagues such as David Klatzmann and Jean-Loup Salzmann. These partnerships have further enriched her research and contributed to advancements in the field.

Conclusion

Charlotte Fribert is a pioneering inventor whose work on synthetic viruses has the potential to revolutionize vaccine development and immune response regulation. Her contributions to the field of immunology are significant and continue to inspire future research.